Tri Chemical Laboratories Inc. (TYO:4369)
Japan · Delayed Price · Currency is JPY 2,480.00
-164.00 (-6.20%)
Nov 6, 2026, 3:30 PM JST
Tri Chemical Laboratories Ratios and Metrics
Market cap in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
| 80,592 | 107,239 | 105,940 | 119,914 | 75,815 | 99,603 | |
Market Cap Growth | -13.68% | 1.23% | -11.65% | 58.16% | -23.88% | -26.21% |
Enterprise Value | 76,295 | 105,702 | 96,529 | 110,626 | 67,816 | 95,897 |
Last Close Price | 2480.00 | 3300.00 | 3226.44 | 3613.75 | 2266.31 | 2939.12 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
PE Ratio | 13.19 | 19.45 | 21.35 | 48.55 | 15.69 | 24.32 |
Forward PE | 11.69 | 18.59 | 18.44 | 32.56 | 14.47 | 21.81 |
PS Ratio | 3.07 | 4.49 | 5.60 | 10.66 | 5.49 | 8.61 |
PB Ratio | 2.11 | 2.97 | 3.35 | 4.35 | 2.93 | 4.67 |
P/TBV Ratio | 2.11 | 2.97 | 3.36 | 4.37 | 2.95 | 4.71 |
P/FCF Ratio | 407.03 | - | 174.82 | 97.25 | 15.59 | 36.13 |
P/OCF Ratio | 13.56 | 28.26 | 28.83 | 40.35 | 11.86 | 27.38 |
PEG Ratio | 0.89 | 1.35 | 0.41 | 5.19 | 1.32 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
EV/Sales Ratio | 2.91 | 4.43 | 5.11 | 9.84 | 4.91 | 8.29 |
EV/EBITDA Ratio | 7.52 | 13.52 | 14.56 | 34.02 | 14.39 | 24.00 |
EV/EBIT Ratio | 9.70 | 17.91 | 18.37 | 56.79 | 19.35 | 32.22 |
EV/FCF Ratio | 385.33 | - | 159.29 | 89.72 | 13.95 | 34.78 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Debt / Equity Ratio | 0.15 | 0.11 | 0.06 | 0.09 | 0.13 | 0.20 |
Debt / EBITDA Ratio | 0.65 | 0.53 | 0.27 | 0.74 | 0.69 | 1.07 |
Debt / FCF Ratio | 29.20 | - | 2.93 | 1.95 | 0.67 | 1.55 |
Net Debt / Equity Ratio | -0.11 | -0.09 | -0.24 | -0.29 | -0.30 | -0.18 |
Net Debt / EBITDA Ratio | -0.49 | -0.40 | -1.16 | -2.49 | -1.67 | -0.94 |
Net Debt / FCF Ratio | -21.70 | 1.27 | -12.64 | -6.57 | -1.62 | -1.36 |
Asset Turnover | 0.58 | 0.57 | 0.55 | 0.35 | 0.46 | 0.48 |
Inventory Turnover | 2.26 | 2.15 | 2.18 | 2.12 | 3.36 | 3.59 |
Quick Ratio | 2.91 | 1.81 | 3.51 | 5.69 | 4.27 | 3.44 |
Current Ratio | 4.37 | 3.06 | 5.13 | 7.45 | 5.15 | 4.15 |
Return on Equity (ROE) | 17.09% | 16.28% | 16.77% | 9.24% | 20.48% | 24.15% |
Return on Assets (ROA) | 9.03% | 8.76% | 9.55% | 3.81% | 7.25% | 7.72% |
Return on Invested Capital (ROIC) | 14.90% | 16.14% | 18.26% | 7.84% | 15.40% | 13.74% |
Return on Capital Employed (ROCE) | 15.10% | 14.90% | 16.00% | 6.60% | 12.30% | 12.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Earnings Yield | 7.58% | 5.14% | 4.68% | 2.06% | 6.37% | 4.11% |
FCF Yield | 0.25% | -2.32% | 0.57% | 1.03% | 6.41% | 2.77% |
Dividend Yield | 1.41% | 1.06% | 1.07% | 0.81% | 1.29% | 0.65% |
Payout Ratio | 18.57% | 20.60% | 19.63% | 39.39% | 13.43% | 12.97% |
Buyback Yield / Dilution | - | 0.00% | 0.00% | 0.00% | -0.25% | -3.74% |
Total Shareholder Return | 1.41% | 1.06% | 1.07% | 0.81% | 1.03% | -3.08% |